Wells Fargo & Company Tandem Diabetes Care Inc Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Wells Fargo & Company holds 61,255 shares of TNDM stock, worth $2.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,255

Previous 45,092 35.84%

Holding current value

$2.04 Million

Previous $1.91 Million 15.44%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$27.34 - $41.78 $441,896 - $675,290	16,163 Added 35.84%	61,255 $2.21 Million
Q3 2024 Nov 13, 2024	BUY	$35.21 - $47.3 $60,420 - $81,166	1,716 Added 3.96%	45,092 $1.91 Million
Q2 2024 Aug 13, 2024	SELL	$30.43 - $53.43 $110,126 - $193,363	-3,619 Reduced 7.7%	43,376 $1.75 Million
Q1 2024 May 10, 2024	BUY	$22.09 - $35.41 $253,173 - $405,834	11,461 Added 32.25%	46,995 $1.66 Million
Q4 2023 Feb 09, 2024	SELL	$14.28 - $31.03 $310,590 - $674,902	-21,750 Reduced 37.97%	35,534 $1.05 Million
Q3 2023 Nov 13, 2023	SELL	$19.33 - $36.22 $263,061 - $492,917	-13,609 Reduced 19.2%	57,284 $1.19 Million
Q2 2023 Aug 15, 2023	BUY	$24.18 - $42.46 $394,061 - $691,970	16,297 Added 29.85%	70,893 $1.74 Million
Q1 2023 May 12, 2023	BUY	$35.86 - $46.5 $197,911 - $256,633	5,519 Added 11.25%	54,596 $2.22 Million
Q4 2022 Feb 13, 2023	SELL	$35.49 - $56.15 $211,236 - $334,204	-5,952 Reduced 10.82%	49,077 $2.21 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $68.97 $51,374 - $80,970	1,174 Added 2.18%	55,029 $2.63 Million
Q2 2022 Aug 12, 2022	SELL	$53.22 - $123.09 $957,853 - $2.22 Million	-17,998 Reduced 25.05%	53,855 $3.19 Million
Q1 2022 May 16, 2022	SELL	$101.89 - $150.09 $1.64 Million - $2.42 Million	-16,114 Reduced 18.32%	71,853 $8.36 Million
Q4 2021 Feb 14, 2022	SELL	$118.18 - $153.21 $10.4 Million - $13.5 Million	-87,926 Reduced 49.99%	87,967 $13.2 Million
Q3 2021 Nov 15, 2021	BUY	$93.51 - $129.4 $87,431 - $120,989	935 Added 0.53%	175,893 $21 Million
Q2 2021 Aug 16, 2021	SELL	$77.0 - $100.19 $4.45 Million - $5.79 Million	-57,829 Reduced 24.84%	174,958 $17 Million
Q1 2021 May 13, 2021	SELL	$81.28 - $104.34 $2.49 Million - $3.2 Million	-30,650 Reduced 11.63%	232,787 $20.5 Million
Q4 2020 Feb 09, 2021	SELL	$86.4 - $121.75 $406,944 - $573,442	-4,710 Reduced 1.76%	263,437 $25.2 Million
Q3 2020 Nov 05, 2020	BUY	$95.43 - $116.09 $4.42 Million - $5.38 Million	46,312 Added 20.88%	268,147 $30.4 Million
Q2 2020 Aug 13, 2020	SELL	$60.05 - $98.92 $3.39 Million - $5.59 Million	-56,504 Reduced 20.3%	221,835 $21.9 Million
Q1 2020 May 14, 2020	BUY	$47.37 - $90.04 $13.2 Million - $25.1 Million	278,339 New	278,339 $17.9 Million

Others Institutions Holding TNDM

# of Institutions

346

Shares Held

70.9M

Call Options Held

3.11M

Put Options Held

181K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.14B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Tandem Diabetes Care Inc Transaction History